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Abstract The choroid plexus (CP), localized in brain ventricles, is the major source of cerebrospinal ﬂuid (CSF) and
participates in the blood-CSF barrier. It is essential for brain immunosurveillance and the clearance of toxics, and for
brain development and activity. Indeed, the CP secretes a large variety of trophic factors in the CSF that impact the
entire brain. These factors are mainly implicated in neurogenesis, but also in the maintenance of brain functions and the
vasculature. In this mini-review, we provide an overview of the various trophic factors secreted by the CP in the CSF,
and describe their roles in the developing, adult and diseased brain.
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Introduction
The choroid plexus (CP) is leaf-like structure suspended in
the cerebrospinal ﬂuid (CSF) and attached to the ependyma
by a thin stalk. It is a highly vascularized structure localized in
the lateral, third and fourth ventricles of the brain. CP
development and structure are highly conserved between
species (Dziegielewska et al., 2001). Its development begins
at early stage embryogenesis after neural tube closure, when
the hindbrain CP in the 4th ventricle ﬁrst appears, followed by
the telencephalic CP in the lateral ventricles and the
diencephalic CP in the 3rd ventricles. Two cells types are
implicated in the formation of CPs: neuroectoderm cells for
the CP epithelium formation; and the mesoderm for the
formation of the CP stroma (Strazielle et al., 2005; Liddelow,
2015; Lun et al., 2015). The developing CP might also
contain neural progenitor-like cells as precursors of neurons
observed later in CP. These cells could assist CP formation
during embryogenesis by providing a neural regulatory
network that modulates CP functions (Itokazu et al., 2006;
Huang et al., 2011; Prasongchean et al., 2015). The
development, formation and speciﬁcation of CPs is guided
by speciﬁc growth and transcription factors (Johansson, 2014;
Liddelow, 2015).
The CP is the principal source of CSF in the brain (Spector
et al., 2015a) and is responsible for the maintenance of brain
homeostasis through regulation of ﬂuid and electrolyte
balance in the central nervous system (CNS). The composi-
tion of CSF is very similar to plasma and is secreted via an
active mechanism by choroidal cells. CP maintains CSF
composition by ﬁltration and by controlling solute and water
movements across the epithelium (Damkier et al., 2013). The
CP is also part of the brain barrier that forms a blood-CSF
barrier implicated in CNS immunosurveillance (Engelhardt et
al., 2001; Meeker et al., 2012; Kunis et al., 2013). It
eliminates toxic peptides from the brain via various
transporters: CP is a sort of “kidney” in the brain (Spector
and Johanson, 2010; Saunders et al., 2013; Spector et al.,
2015b). Also, many functions are attributed to the CSF, such
as the regulation of intracranial pressure and brain volume,
nutrient transport, drainage, immune regulation, and the
transport of proteins and peptides coming from the CP
(Chodobski and Szmydynger-Chodobska, 2001; Redzic and
Segal, 2004; Strazielle et al., 2005; Spector et al., 2015b).
Indeed, the CP secretes many proteins and peptides in the
CSF, such as hormones, growth factors, homeoproteins, etc,
which can easily diffuse throughout the brain (Johanson et al.,
2011b) and affect both developing and adult brain. In this
short review, we will focus on growth factors and
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neurotrophic factors expressed by the CP and explore their
implications in the developing and adult brain, in health and
disease.
Impact of choroid plexus trophic factors in
the developing brain
During early brain development, the ventricles occupy the
majority of the cranial volume and are ﬁlled with circulating
CSF that originates from choroid epithelial cells. This ﬂuid
contains many proteins that regulate brain development and
neurogenesis by signaling and feeding rapidly dividing
progenitors along the ventricular walls (Zappaterra and
Lehtinen, 2012; Falcão et al., 2012; Gato et al., 2014).
Upon secretion into the ventricle, molecules from the CP are
conveyed by CSF bulk ﬂow to the various regions of the
developing brain (Miyan et al., 2003). Also, certain proteins
secreted by CP cells impact the development and main-
tenance of the CP itself via autocrine signaling. Among these
proteins that orchestrate proper brain development are
numerous growth factors, neurotrophic factors and morpho-
gens (Fig. 1).
The major growth factors found in embryonic CSF include
transforming growth factor (TGF), insulin growth factor
(IGF) and ﬁbroblast growth factor (FGF). The TGF-β family,
including bone morphogenic proteins (BMPs) and the growth
differentiation factors (GDFs), are involved in the developing
brain by promoting cell growth and proliferation, and
inhibiting neuronal death (Falk et al., 2008). BMP7 has
recently been shown to regulate the survival, proliferation and
neurogenic properties of neural precursor cells during brain
corticogenesis (Segklia et al., 2012). BMP7 from CP also
directly attenuates the differentiation of the adjacent neural
progenitors, maintaining a pool of progenitors (Krizhanovsky
and Ben-Arie, 2006). TGF-β2 and TGF-β3 are important
regulators of neuron survival, while GDF-15 is important for
developing and injured neurons, via its protective action
against death (Strelau et al., 2000). BMPs are also important
for the speciﬁcation of CP epithelium. The inhibition of BMP
signaling can result the absence of CP (Hébert et al., 2002),
whereas BMP4 alone is sufﬁcient to induce CP epithelial cells
from embryonic stem cell-derived neuroepithelial progenitors
(Watanabe et al., 2012).
IGF acts on the developing CP for its function and
maintenance (Nilsson et al., 1996) and is expressed and
secreted by CP cells (Salehi et al., 2009; Lehtinen et al.,
2011). During development, IGF promotes the proliferation,
migration and differentiation of immature glial and neuronal
cells (Lehtinen et al., 2011; Ziegler et al., 2012).
In early CP development, FGF expression, particularly
FGF2, modulates gene expression and activity, suggesting
that FGF signaling maintains CP integrity and function
(Greenwood et al., 2008). Secreted FGF2 has also been
shown to have a role in the developing brain by regulating cell
proliferation/neurogenesis and corticogenesis (Vaccarino et
al., 1999; Mashayekhi et al., 2011).
Neurotrophic factors are also highly expressed in the
developing brain, during the phase of neurogenesis (Maison-
pierre et al., 1990). Nerve growth factor (NGF) and
neurotrophins (NT) are all expressed and secreted by the
CP in the CSF. NGF, NT3 and NT4 promote proliferation,
survival, and neurochemical differentiation of selected
neuronal populations in the CNS (Xia et al., 2000; Das et
al., 2001; Mashayekhi et al., 2009).
The CP secretes other proteins and molecules that impact
brain patterning and activity. Sonic hedgehog (Shh) con-
tributes to the CP development by acting on the progenitor
pool of CP epithelial cells, and permitting CP expansion
(Huang et al., 2009). Shh has also been shown to coordinate
the vascular development in CP (Nielsen and Dymecki,
2010). Transthyretin (TTR), also known as prealbumin, is
secreted by the CP and carries the thyroid hormone thyroxin
and retinol binding protein. TTR and thyroid hormones have
an important role in regulating brain expansion and growth
(Alshehri et al., 2015). Some studies have shown that CP
expresses g-aminobutyric acid (GABA) and glutamic acid
decarboxylase 65 (GAD65), suggesting a production of non-
neuronal GABAwhich can modulate the properties of neural
progenitors in the developing cortex (Tochitani and Kondo,
2013).
Impact of choroid plexus trophic factors in
the adult brain
In the adult brain, while the ventricles now occupy very little
volume, the CP continues to secrete growth and transcription
factors in the CSF, including FGF, epithelial growth factor
(EGF), TGF-β, platelet derived growth factor (PDGF), IGF,
vascular endothelial growth factor (VEGF), and the homeo-
protein Otx2 (Fig. 1). Many of these factors are implicated in
either adult neurogenesis, plasticity, cognition or angiogen-
esis (Marques et al., 2011; Falcão et al., 2012; Stolp and
Molnár, 2015). Indeed, the CSF can impact the entire brain,
due to its capacity to diffuse around the brain and in the
parenchyma, along vessels (Iliff et al., 2012; Brinker et al.,
2014).
FGF2 injected or infused in the CSF has been shown to
increase adult neurogenesis in the subventricular zone (SVZ)
and the dentate gyrus (Wagner et al., 1999; Cheng et al.,
2002). FGF2 and EGF also maintain neural niche architecture
and cell lineage progression (Jin et al., 2003). EGF, infused in
the ventricle, increases the proliferation of progenitors cells in
the SVZ, and induces their migration and differentiation
(Craig et al., 1996; Doetsch et al., 2002).
PDGF is implicated in the maintenance of adult cell types.
There is evidence that PDGF contributes to the differentiation
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Figure 1 Secretion and roles of trophic factors in the developing and adult brain. The choroid plexus (CP) secretes many trophic factors
that impact the developing and adult brain, in health and in disease. During development (top panel), trophic factors guide brain formation
through their roles in neurogenesis, vasculature development and brain expansion/maturation. In the adult brain (middle panel), the CP
continues to secrete trophic factors that impact and maintain adult neurogenesis and brain maturation/function. In some diseases (bottom
panel), such as those involving neurodegeneration, the CP atrophies and/or trophic factor secretion is altered. These changes can lead to
neuroinﬂammation, impaired neurogenesis, and compromised vasculature that ultimately result in brain deﬁcits. CP: choroid plexus, CSF:
cerebrospinal ﬂuid, VEGF: vascular endothelial growth factor, IGF: insulin growth factor, FGF: ﬁbroblast growth factor, EGF: epithelial
growth factor, PDGF: platelet-derived growth factor, NT: neurotrophins, TGF: transforming growth factor, TNF: tumor necrosis factor,
IFN: interferons, NSC: neural stem cells.
Karen Arnaud and Ariel A. Di Nardo 3
of oligodendrocytes in adulthood, and increases proliferation
in SVZ (Jackson et al., 2006). SVZ progenitors express
PDGF receptors and increase proliferation in response to
PDGF signaling (Moore et al., 2014).
In adult brain, VEGF directly regulates the proliferation of
adult stem cells, and promotes cell survival and axonal
outgrowth (Schänzer et al., 2004; Mackenzie and Ruhrberg,
2012). VEGF is also implicated in the maintenance of CP in
adult brain by sustaining normal vasculature (Maharaj et al.,
2008). It also affects the proliferation, growth and migration
of cells by helping to form angiogenic niches important for
neurogenesis, and by acting directly on cells to promote
proliferation (Jin et al., 2002; Ruiz de Almodovar et al., 2010;
Licht et al., 2010; Mackenzie and Ruhrberg, 2012).
IGF-II promotes the self-renewal of neural progenitors/
stem cells (Ziegler et al., 2012，2015), and the IGF family
has been shown to stimulate neurogenesis and protect cells
against injury (Ziegler et al., 2015). IGF also enhances
memory by its neurotrophic action on glutamatergic
synapses, within hippocampal circuits (Werner and LeRoith,
2014). However, Igf2 levels are greatly reduced in the adult
compared to embryonic CSF (Lehtinen et al., 2011). This
same study also showed that several BMPs continue to be
expressed in adult CP and retain similar CSF activity
(Lehtinen et al., 2011).
Neurotrophic factors have a reduced role in adult CSF.
Brain-derived neurotrophic factor (BDNF) can increase adult
proliferation and cell survival (Pencea et al., 2001; Binder and
Scharfman, 2004), while NT3 is implicated in the quiescence
and long-term maintenance of adult stem cells (Delgado et al.,
2014). BDNF also appears essential for molecular mechan-
isms of synaptic plasticity (Binder and Scharfman, 2004;
Budni et al., 2015).
Others molecules secreted by the CP in adulthood that are
implicated in cell proliferation, self-renewal, survival, and
migration include Wnt, Shh, ephrins, semaphorins, Slits, and
Robo (Falcão et al., 2012). Transcription factors have also
been found in CSF. The Otx2 homeoprotein is secreted by CP
in postnatal CSF and accumulates in cortical interneurons to
help regulate the timing of periods of hightened circuit
plasticity shaped by sensory experience (Spatazza et al.,
2013).
Impact of choroid plexus trophic factors in
aging and diseases
Aging impacts CP: the secretion of CSF is reduced and the
production of growth factors decreases (Fig. 1) (Redzic et al.,
2005; Chen et al., 2012). CP cells themselves are impacted,
with morphological and metabolism modiﬁcations, and
decreased capacity of neuroprotection. Brain permeability
can increase with age, due to attenuated CP barrier,
potentially resulting in the entry of inﬂammatory and toxic
molecules in the brain. CSF turnover is modiﬁed, resulting in
reduced ability to clear proteins from CSF, which can lead to
an accumulation of toxic molecules in the aged brain
(Preston, 2001; Emerich et al., 2005).
Furthermore, aging is accompanied by reduced production
of growth factors, leading to a decrease in adult neurogenesis
(Emerich et al., 2004). However, treatment with growth
factors during aging could partially revitalize neurogenesis:
as CP cells produce a huge quantity of IGF, which is
important for neurogenesis and cell turnover, aging CP could
have signiﬁcant consequence for tissue repair and brain
functioning. IGF-1 supplementation can reverse cognitive
deﬁcits induced by aging, and can restore normal hippocam-
pal activities (Ashpole et al., 2015). Growth Hormone (GH)
has been shown to have the same effect on aging brain
(Ashpole et al., 2015). With age, the production of BDNF,
NGF and GDNF is modiﬁed, resulting in reduced neuronal
survival and neurogenesis eventually leading to cognitive
impairment (Budni et al., 2015). On the other hand, CP
produces new molecules during aging, such as interferon type
I (IFN-I), whereas IFN-II production decreases. Changes in
IFN levels lead to modiﬁed brain function, such as cognitive
deﬁcits, hippocampal dysfunctions, neuroinﬂammation, and
decreased neurogenesis (Baruch et al., 2014).
Aging is strongly associated with Alzheimer’s disease
(AD), the most common neurodegenerative disease. AD is
characterized by cognitive deﬁcits, memory loss and neuronal
loss, and is linked to modiﬁcations in CP functions. In AD,
CP can have an altered structure (Serot et al., 1997, 2001). It
normally has a role in the clearance of amyloid fragments, a
hallmark of AD, but with disease progression, this CP
function is altered and the clearance becomes incomplete
(González-Marrero et al., 2015). The barrier and “kidney”
functions of CP appear to be less efﬁcient. This dysfunction is
associated with a reduction in trophic factor production,
leading to reduced neuroprotection against AD hallmarks
(Krzyzanowska and Carro, 2012). Certain trophic factors can
help the clearance of toxic peptides, such as FGF2 and IGF-1
(Johanson et al., 2004; Carro et al., 2006). But with the
progression of AD, a vicious circle appears: low levels of
trophic factors induce clearance deﬁcits, which leads to a
decrease in factor secretion by the CP. The production of
BDNF, NGF and GDF is also modiﬁed in compensation
during AD: in early stages their concentrations increase,
whereas in later stages, they are decreased. In later stages,
these modiﬁcations probably encourage neuronal loss and
memory deﬁcits (Budni et al., 2015; Forlenza et al., 2015).
Neuroinﬂammation is present throughout all AD stages. In
early stages, IFN-I, IFN-II and TNF-α levels contribute to
neuroprotection by increasing the migration of new cells in
the brain (Ben-Hur et al., 2003). But in later stages, IFN-I and
IFN-II CSF levels are increased, leading to cell death,
suggesting a role in the development of AD pathology
(Mesquita et al., 2015).
In other neurodegenerative diseases, CSF trophic factors
are also modiﬁed. In amyotrophic lateral sclerosis (ALS),
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FGF is increased in the CSF and serum of patients, possibly
as a compensation phenomenon for protection against cell
apoptosis and neuronal loss (Gong et al., 2015). In AD, ALS
and Huntington’s disease (HD), modiﬁed VEGF levels lead
to vascular and neuroprotection impairments (Storkebaum
and Carmeliet, 2004). In ALS, it has been shown that altered
VEGF levels are indicative of the activation of compensatory
responses, which may reﬂect the disease progression (Gao et
al., 2014).
Neuroinﬂammation is often associated with neurodegen-
erative diseases. Accordingly, many inﬂammatory factors,
which could also act as neurotrophic factors, are expressed.
Increases in IFN-I, IFN-II and TNF-α levels are also changed:
they are linked to neurodegeneration pathways in Parkinson’s
disease (PD), ALS, multiple sclerosis (MS), while contribut-
ing to neuroinﬂammation (McCoy and Tansey, 2008). Other
cytokines and pro-inﬂammatory proteins are also released by
the CP, such as CXCL12 and IL1-β, and have been shown to
decrease adult neurogenesis as a consequence of brain
inﬂammation (Stolp and Molnár, 2015).
The secretion of trophic factors can also be regulated
during brain injury, such as stroke. During such an event, CP
is altered and the barrier can become compromised. However,
CP can react to protect the brain against the lesion/ischemia
and to induce brain regeneration/repair. CP expression of
trophic factors, such as IGF-II, EGF, NGF, GDNF, BDNF,
VEGF, and TNF, are implicated in the stimulation of adult
neurogenesis, angiogenesis and neuroprotection/cell survival
(Johanson et al., 2011a; Zappaterra and Lehtinen, 2012). CP
cells have also been implicated directly in tissue regeneration,
acting as progenitor cells in injured brain (Li et al., 2002).
Under stress conditions, trophic factor levels are modiﬁed
in the CSF, owing to altered CP secretion and structure, and
might be linked to psychiatric disorders. In major depressive
disorder (MDD), modiﬁed expression of FGF family factors
alter hippocampal functions pertaining to mood and emotions
(Aurbach et al., 2015). However, another recent study found
no difference in CP growth factor production in MDD
patients (Turner et al., 2014), other than a decrease in TGF-β.
It has also been shown that stress can modify BDNF, IGF1,
TNF-α and IL1-β production/expression in CP (Sathyanesan
et al., 2012). In bipolar disorder (BD), BDNF is decreased,
with implications in the depression or “active” phases,
possibly linked to its role in synaptic function and memory
consolidation (Pillai et al., 2010; Rabie et al., 2014). The
levels of NGF, BNDF, NT4 and NT5, GDNF, IGF1 and
VEGF can be modiﬁed during different disease stages and
with varying outcomes for BD pathology (Scola and
Andreazza, 2015).
Outlook
The CP secretes many different trophic factors, important in
the developing and adult brain. These factors act in the
normal brain, but they are also implicated and modiﬁed in
many diseases. The potential therapeutic effect of CP cells has
not escaped attention, and their transplantation in the diseased
brain has been envisioned. The CP is itself a potentially
powerful therapeutic target, as it provides a means of
suppressing or activating trophic factor levels throughout
the brain.
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